GSK3B and ovarian carcinoma: Western blot results showed that the expression of P-PI3K/PI3K, P-AKT/AKT and P-GSK3B/GSK3B were reduced in ovarian cancer cells in the CE-treated group compared with the control group (Figures 13A-D).